StatOrigin open statistical archive
Industries Indicators Regions Rankings Compare Sources

Clinical trial country use share

Percentage of total clinical trial country uses accounted for by a given region.

Unit Percent Industry Pharmaceuticals

Cite & reuse Get this data as JSON
Records
10
Regions
4
Period
2019–2025
Sources
1
Verification 10 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

Across regions

3 regions on one axis, spaced by time. Below it, the latest value of every region, ranked. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Clinical trial country use share by region

3 of 4 regions drawn, 2019 to 2025; every region is ranked below

3 regions · 8 observations · 2019 to 2025
Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
Clinical trial country use share by regionClinical trial country use share by region. 3 regions on one axis: European Union, North America, China. 8 observations from 2019 to 2025, ranging from 10% to 32%. Latest values: European Union 27% (2025); North America 23% (2023); China 15% (2023). % 0 10 20 30 40 2019 2020 2021 2022 2023 2024 2025 European Union North America China
View the underlying data
Clinical trial country use share by region
Region Period Type Value
European Union 2025 Actual 27%
European Union 2023 Actual 25%
European Union 2019 Actual 32%
North America 2023 Actual 23%
North America 2019 Actual 19%
China 2023 Actual 15%
China 2021–2023 Actual 13%
China 2019 Actual 10%
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/pharmaceuticals--clinical-trial-country-use-share--regions" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Clinical trial country use share by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/clinical-trial-country-use-share">Clinical trial country use share by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Clinical trial country use share by region

Latest value per region, periods differ

4 entries · ranked

Latest available period per row; periods differ

Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
Clinical trial country use share by regionClinical trial country use share by region. 4 categories, highest is European Union at 27%. Bars refer to different periods; each is labelled with its own. China 2023 United States 2021–2023 North America 2023 European Union 2025 15% 16% 23% 27%
View the underlying data
Clinical trial country use share by region
Category Period Source Type Value
European Union 2025 IQVIA Actual 27%
North America 2023 IQVIA Actual 23%
United States 2021–2023 IQVIA Actual 16%
China 2023 IQVIA Actual 15%
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable. 

<iframe src="https://statorigin.org/embed/pharmaceuticals--clinical-trial-country-use-share--by-region" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Clinical trial country use share by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/clinical-trial-country-use-share">Clinical trial country use share by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

10 records · 4 regions · 2019–2025

Download CSV JSON series
Clinical trial country use share: every record, grouped by region, newest first.
Period Value Source Type
European Union 4 records
2025 27% IQVIA · 31 Dec 2025 actual
2025 27% IQVIA · 31 Dec 2025 actual
2023 25% IQVIA · 31 Dec 2023 actual
2019 32% IQVIA · 31 Dec 2019 actual
North America 2 records
2023 23% IQVIA · 31 Dec 2023 actual
2019 19% IQVIA · 31 Dec 2019 actual
United States 1 record
2021–2023 16% IQVIA · 31 Dec 2023 actual
China 3 records
2023 15% IQVIA · 31 Dec 2023 actual
2021–2023 13% IQVIA · 31 Dec 2023 actual
2019 10% IQVIA · 31 Dec 2019 actual

Primary documents

Sources

3 documents. Each links to the publisher's own copy.

Document Publisher Published Data points
Global R&D Trends 2026 IQVIA — 1
Global R&D Trends 2026 IQVIA — 1
Rethinking Clinical Trial Country Prioritization IQVIA — 8

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Clinical trial country use share. Retrieved from https://statorigin.org/indicators/clinical-trial-country-use-share

Download CSV Get this data as JSON Compare with… API docs